Zymafos News
Most Popular Zymafos Story
Ziopharm soars on promising cancer data
Shares of Ziopharm Oncology zoomed up 37 percent this morning after the developer released promising mid-stage data on its cancer drug Zymafos. The company decided to stop enrolling new patients into Read more...
Latest Headlines
- October 14, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
